This article discusses the recent wave of state bills on food additives that have emerged following the California Food Safety Act, FDA’s activities in an effort to get ahead of an inconsistent patchwork of legislation, and criticisms about these bills voiced by legislators, regulators, and industry stakeholders.
Results of sampling and testing of imported honey for signs of economically motivated adulteration conducted by the U.S. Food and Drug Administration (FDA) in 2022–2023 has revealed only 3 percent of samples to be violative.
In this episode of Food Safety Matters, we are joined by James (Jim) Jones, FDA's first Deputy Commissioner for Human Foods, about his charge of implementing and leading a unified and effective Human Foods Program, the importance of stakeholder engagement in decision-making, and the agency’s current work in food safety.
The U.S. House of Representatives’ Committee on Oversight and Accountability will hold a hearing on April 11, 2024 to question FDA Commissioner Robert M. Califf, M.D. about the agency’s failure to prevent recent food safety crises.
In light of recently confirmed cases of highly pathogenic avian influenza (HPAI) in U.S. dairy cows and now in one person, James (Jim) Jones, FDA Deputy Commissioner for Human Foods revealed that HPAI has become the “highest priority” within the agency’s Human Foods Program, and that the agency has set up a set up a dedicated Incident Management Team (IMT) to respond to the developing threat.
In an April 5 webinar, FDA Deputy Commissioner for Human Foods James (Jim) Jones spoke in great detail about the agency’s fiscal year (FY) 2025 Presidential budget request, and how portions of those funds will be allocated to meeting Human Foods Program goals.
The U.S. Food and Drug Administration (FDA) has released its new Integrated Food Safety System Regulatory and Laboratory Training System (IFSS RLTS) Strategic Plan 2024–2028, and will hold a stakeholder call on April 2, 2024.
FDA has partnered with U.S. Customs and Border Protection (CBP) to expand the focus of the Global Business Identifier (GBI) Test, which is examining how identifiers—unique numbers that capture information about legal business entities and their functions—can be leveraged to address a range of supply chain traceability needs.
The U.S. Food and Drug Administration (FDA) now offers several resources to help state, local, territorial, and tribal jurisdictions complete a risk factor study as part of Standard 9 (Program Assessment) of the Voluntary National Retail Food Regulatory Program Standards.
FDA will hold a one-day virtual public meeting on Data and Technology in the New Era of Smarter Food Safety on April 24, 2024 to better understand how the agency can leverage data and technology to advance food safety. The same day, FDA will also open a docket to collect public comment on the event topic.
RSS
